[
    {
        "other_ids": [],
        "amendment_date": "2022-01-18",
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Icahn School of Medicine at Mount Sinai",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Women or men with metastatic breast cancer, measurable or evaluable disease including bone metastasis only (as per the Response Evaluation Criteria in Solid Tumors [RECIST] v1.1)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "No prior systemic treatment for metastatic breast cancer"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Pathologic confirmation of metastatic breast cancer diagnosed by core needle biopsy. Fine needle aspiration (FNA) or cytology is acceptable if patient is diagnosed with de novo metastatic disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Metastatic breast cancer with any evidence of estrogen receptor (ER) or progesterone receptor (PR) positivity in >= 1% cells in biopsy specimens from either a primary or metastatic site is eligible"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Evidence of HER2 positive metastatic breast cancer in either a primary or metastatic site, if 3+ by an immunohistochemistry (IHC) method defined as uniform membrane staining for HER2 in 10% or more of tumor cells or demonstrate HER2 gene amplification by an in situ hybridization (ISH) method (single probe, average HER2 copy number >= 6.0 signals/cell; dual probe HER2/chromosome enumeration probe [CEP] 17 ratio >= 2.0 with an average HER2 copy number >= 4.0 signals/cell; dual probe HER2/CEP 17 ratio >= 2.0 with an average HER2 copy number < 4.0 signals/cell; and HER2/CEP17 ratio < 2.0 with an average HER2 copy number >= 6.0 signals/cell) or amplified by fluorescence in situ hybridization (FISH) > 2.0; high average copy number of HER2 (>= 6.0 signals/cell) is considered positive regardless of the HER2/CEP17 ratio"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Stable brain metastasis allowed (> 2 weeks, clinically stable post treatment with surgery +/- radiation or radiation alone and off steroids)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Transthoracic echocardiogram with ejection fraction > 50%"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Postmenopausal status or receiving ovarian ablation with a gonadotropin-releasing hormone (GnRH) agonist such as goserelin or leuprolide; postmenopausal status is defined by any one of the following criteria:\r\n* Prior bilateral oophorectomy\r\n* Prior ovarian radiation for the purpose of ablation\r\n* Age >= 60 years\r\n* Age < 60 and amenorrhea for 12 or more months (in the absence of chemotherapy, tamoxifen, or ovarian suppression) and follicle stimulating hormones (FSH), luteinizing (LH), and estradiol in the postmenopausal range per local normal"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Absolute neutrophil count (ANC) >= 1,500/mm^3 (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Platelet count >= 75,000/ mm^3 (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Hemoglobin (Hg) > 9 g/dL (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Total bilirubin =< 1.5 x upper limits of normal (ULN) (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 2.5 x ULN (=< 5 x ULN in patients with liver metastasis) (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Creatinine =< 1.5 x ULN (=< 28 days prior to registration)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "Written informed consent prior to beginning specific protocol procedures, including expected cooperation of the patients for the treatment and follow-up, must be obtained and documented according to the local regulatory requirements"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "A baseline computed tomography (CT) chest/abdomen/pelvis and bone scan or positron emission tomography (PET)/CT"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Negative serum or urine pregnancy test within 7 days prior to starting treatment (for women of childbearing potential only)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "Women of child-bearing potential and men must agree to use adequate contraception prior to study entry, for the duration of study participation, and for 90 days following completion of therapy; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately\r\n* Note: Recommended methods of birth control are: The consistent use of an intrauterine device (IUD), double barrier methods (diaphragm with spermicidal gel or condoms with contraceptive foam), sexual abstinence (no sexual intercourse) or sterilization; men must agree to use a condom and not father a child for the duration of the study and for 90 days after completion of therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "HER2 negative metastatic breast carcinoma defined as 0 or 1+ by IHC or with a FISH ratio (HER2 gene copy/ chromosome 17) < 2 if IHC 2+ by local institution standard protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Any prior treatment for metastatic breast cancer (excluding radiation therapy for the purpose of ovarian ablation). Note: prior adjuvant therapy with trastuzumab and pertuzumab is permitted after a 6-month window following completion of adjuvant therapy has passed"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Patients currently receiving anticancer therapies or who have received anticancer therapies within 2 weeks of the start of study drug (including chemotherapy, radiation therapy, and biologics). Patients who have received prior endocrine therapy for fertility purposes will be eligible"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Patients, who have had a major surgery or significant traumatic injury within 4 weeks of start of study drug, patients who have not recovered from the side effects of any major surgery (defined as requiring general anesthesia) or patients that may require major surgery during the course of the study"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Prior treatment with any investigational drug within the preceding 2 weeks"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Co-administration with strong CYP3A4 inducers (e.g., phenytoin, rifampin, carbamazepine, St John\u2019s Wort, bosentan, efavirenz, etravirine, modafinil, and nafcillin), strong CYP3A4 inhibitors (e.g., clarithromycin, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir, telaprevir, telithromycin, verapamil, and voriconazole), and CYP3A4 substrates (e.g., alfentanil, cyclosporine, dihydroergotamine, ergotamine, everolimus, fentanyl, pimozide, quinidine, sirolimus and tacrolimus), aprepitant, aripiprazole, clozapine, dasatinib, fosaprepitant, grapefruit juice and nivolumab\r\n* The Lexicomp drug interaction calculator will be used to examine all medications taken by subjects and palbociclib. Interactions defined as A (No know interaction), B (No action needed) or C (Monitor Therapy) are allowed on the study while interactions D (Consider therapy modification) and X (Avoid Combination) are not allowed. Of note, the use of dexamethasone to prevent an infusion reaction is permitted"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Uncontrolled brain metastases"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Leptomeningeal metastases"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Other malignancies within the past 3 years except for adequately treated carcinoma of the cervix or basal or squamous cell carcinomas of the skin"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Patients who have any severe and/or uncontrolled medical conditions or other conditions that could affect their participation in the study such as:\r\n* Symptomatic congestive heart failure of New York heart Association Class III or IV\r\n* Unstable angina pectoris, symptomatic congestive heart failure, myocardial infarction within 6 months of start of study drug, serious uncontrolled cardiac arrhythmia or any other clinically significant cardiac disease\r\n* Severely impaired lung function as defined as spirometry and diffusion capacity of the lung for carbon monoxide (DLCO) that is 50% of the normal predicted value and/or oxygen (O2) saturation that is 89% or less at rest on room air\r\n* Uncontrolled diabetes as defined by fasting serum glucose >1.5 x ULN. Fasting serum glucose will only be obtained if non-fasting glucose at screening is high per the treating investigator\r\n* Active (acute or chronic) or uncontrolled severe infections\r\n* Liver disease such as cirrhosis, chronic active hepatitis or chronic persistent hepatitis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of palbociclib (e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome or small bowel resection)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "Patients with an active, bleeding diathesis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "History of noncompliance to medical regimens"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Patients unwilling to or unable to comply with the protocol"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Ongoing alcohol or drug addiction"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Female patients who are pregnant or breast feeding, or adults of reproductive potential who are not using effective birth control methods; if barrier contraceptives are being used, these must be continued throughout the trial by both sexes; hormonal contraceptives are not acceptable as a method of contraception; (women of childbearing potential must have a negative urine or serum pregnancy test within 7 days prior to starting treatment)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to palbociclib, anastrozole, trastuzumab or pertuzumab"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "PRIMARY OBJECTIVES:\r\nI. To determine the dose-limiting toxicity (DLT) and maximally tolerated dose (MTD) for palbociclib when administered in combination with anastrozole, trastuzumab and pertuzumab. (Phase I)\r\nII. To determine the clinical benefit rate (CBR) of treatment with anastrozole, palbociclib, trastuzumab, and pertuzumab in HR+, HER2+ metastatic breast cancer patients. (Phase II)\r\n\r\nSECONDARY OBJECTIVES:\r\nI. To describe the adverse events associated with anastrozole, palbociclib, trastuzumab, and pertuzumab. (Phase I)\r\nII. To determine progression free survival in HR+, HER2+ metastatic breast cancer patients treated with anastrozole, palbociclib, trastuzumab, and pertuzumab. (Phase II)\r\nIII. To determine the type, incidence, severity (as graded by the National Cancer Institute Common Terminology Criteria for Adverse Events [NCI CTCAE] version [v.] 4.0), seriousness and relationship to study medications of adverse events (AEs) and any laboratory abnormalities at the MTD. (Phase II)\r\n\r\nEXPLORATORY OBJECTIVES:\r\nI. To determine potential biomarkers of response to palbociclib including cyclin D1 expression levels, cytoplasmic cyclin E levels, phosphorylated retinoblastoma expression, retinoblastoma, p16 levels and CDKs 2, 4 and 6.\r\nII. To determine potential mechanisms of resistance that may develop with treatment.\r\n\r\nOUTLINE: This is a phase I, dose escalation study of palbociclib followed by a phase II study.\r\n\r\nParticipants receive anastrozole orally (PO) once daily (QD) on days 1-28, and palbociclib PO QD on days 1-21. Participants also receive trastuzumab intravenously (IV) over 30-90 minutes and pertuzumab IV over 30-60 minutes once every 21 days. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.\r\n\r\nAfter completion of study treatment, participants are followed-up at 30 days and then every 6 months for up to 2 years.",
        "official_title": "A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab in HR-Positive, Her2-Positive Metastatic Breast Cancer (ASPIRE)",
        "_phase_sort_order": 3,
        "collaborators": [
            {
                "name": "National Cancer Institute",
                "functional_role": "FUNDING_SOURCE"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of CDKs 2, 4 and 6 expression",
                "description": "Will assess the change in CDKs 2, 4 and 6 expression between baseline biopsy and tissue biopsy obtained at the time of progressive disease using a paired t-test.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of change in cyclin D1 expression with response to therapy",
                "description": "To assess change in cyclin D1 expression with response to therapy, the\r\nproportion of patients responsive to treatment will be computed and compared between cyclin D1 positive and negative patient groups, using a Fisher\u2019s exact test of association.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of changes in cytoplasmic cyclin E",
                "description": "Proportion of patients responsive to treatment will be computed and compared between cytoplasmic cyclin E positive and negative patient groups, using a Fisher\u2019s exact test of association.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of p16 levels at baseline and response to therapy",
                "description": "To assess differences in p16 levels at baseline and response to therapy, study will perform an analysis of covariance on baseline p16 level and the proportion of patients responsive to treatment. Will assess the change in Ki-67 expression between baseline biopsy and tissue biopsy obtained at the time of progressive disease using a paired t-test.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of phosphorylated retinoblastoma",
                "description": "Will assess the change in phosphorylated retinoblastoma expression between baseline biopsy and tissue biopsy obtained at the time of progressive disease using a paired t-test.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Baseline and at 30 days post-treatment",
                "name": "Assessment of resistance mechanisms",
                "description": "To determine potential mechanisms of resistance that may develop with\r\ntreatment by way of ribonucleic acid (RNA) sequencing of baseline biopsies and biopsies obtained at the time of progression.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 6 months",
                "name": "Clinical benefit rate (CBR) (Phase II)",
                "description": "CBR will be reported as a percentage of the total number of subjects enrolled in the response-evaluable population with stable disease or better (stable disease, partial response, or complete response) at their 3 and 6 cycle response assessments. Following the non-responder imputation method, subjects who do not have an imaging evaluation at their 6 cycle assessment will be assumed to be non-responders in the analysis. A two-sided 80% confidence interval for the CBR percentage will be computed using the methods and software introduced by Koyama and Chen which accounts for the group sequential nature of the design.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 2 years",
                "name": "Incidence of adverse events graded according to CTCAE version 4.0 (Phase I)",
                "description": "Overall and for each dose, the toxicity and complication profile associated with anastrozole, palbociclib, trastuzumab and pertuzumab will be assessed.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 28 days",
                "name": "Maximum tolerated dose (MTD) and dose limiting toxicity (DLT) (Phase I)",
                "description": "MTD to be determined by the dose limiting toxicity. The MTD is defined as the highest dose of palbociclib that does not yield unacceptable toxicity. These will be assessed via the National Cancer Institute's (NCI\u2019s) Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Specifically, if > 33% of patients experience a DLT at any dose level, the dose level below that level will be considered the MTD. Or if the highest level has been reached and \u2264 33% of patients experience a DLT, that will be considered the MTD. A 3+3 dose escalation trial design for this part of the study will be used to determine the MTD.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From the date of randomization up to 2 years",
                "name": "Progression free survival (PFS) (Phase II)",
                "description": "PFS to be defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. PFS is defined as the time from the date of randomization to confirmed disease progression or death from any cause, whichever occurs first. If the patient has not had an event, progression free-survival will be censored as the date of last tumor assessment. Progression-free survival curves will be estimated by using the Kaplan-Meier method. Kaplan-Meier estimates for median time to progression and the associated 95% confidence interval will be reported.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03304080",
        "biomarkers": [
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35681"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C54362"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HR Status"
                ],
                "nci_thesaurus_concept_id": "C188928",
                "name": "Hormone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C36292",
                    "C94299"
                ],
                "parents": [
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C38349",
                    "C94299",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C21295",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C38349",
                    "C94299",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C21295",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165744",
                "name": "Hormone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C35681",
                    "C77140",
                    "C3367",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C165233",
                    "C188928"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C54362"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Negative",
                    "ER Negative",
                    "ER-",
                    "ER-Alpha Negative",
                    "ERA Negative",
                    "ESR Negative",
                    "ESR1 Negative",
                    "ESRA Negative",
                    "ESTRR Negative",
                    "Estrogen Receptor 1 Negative",
                    "Estrogen Receptor Alpha Negative",
                    "NR3A1 Negative",
                    "Negative",
                    "Negative Estrogen Receptor",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Negative"
                ],
                "nci_thesaurus_concept_id": "C15493",
                "name": "Estrogen Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C165744",
                    "C21295",
                    "C35681",
                    "C77140",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C38349",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16150"
                ],
                "parents": [
                    "C16150",
                    "C165744",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "PGR Positive",
                    "PR Positive",
                    "PR+",
                    "Positive"
                ],
                "nci_thesaurus_concept_id": "C15496",
                "name": "Progesterone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C177692",
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C101267",
                    "C20420",
                    "C38349",
                    "C3367",
                    "C35682",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16149"
                ],
                "parents": [
                    "C101267",
                    "C16149",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Positive",
                    "ER Positive",
                    "ER+",
                    "ER-Alpha Positive",
                    "ERA Positive",
                    "ESR Positive",
                    "ESR1 Positive",
                    "ESRA Positive",
                    "ESTRR Positive",
                    "Estrogen Receptor 1 Positive",
                    "Estrogen Receptor Alpha Positive",
                    "NR3A1 Positive",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Positive",
                    "Positive",
                    "Positive Estrogen Receptor"
                ],
                "nci_thesaurus_concept_id": "C15492",
                "name": "Estrogen Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C16150",
                    "C3367",
                    "C77140",
                    "C20103",
                    "C101267",
                    "C20420",
                    "C28656",
                    "C16612",
                    "C94299",
                    "C38349",
                    "C188928",
                    "C54362",
                    "C20709",
                    "C177692",
                    "C21295",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C101267",
                    "C16150",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HR Status"
                ],
                "nci_thesaurus_concept_id": "C188928",
                "name": "Hormone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C36292",
                    "C94299"
                ],
                "parents": [
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Positive",
                    "HER-2 Positive",
                    "HER2 Positive"
                ],
                "nci_thesaurus_concept_id": "C68748",
                "name": "HER2/Neu Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C177692",
                    "C21281",
                    "C17756",
                    "C25871",
                    "C25872",
                    "C94299",
                    "C35682",
                    "C36292",
                    "C21295",
                    "C77140",
                    "C16612",
                    "C16152",
                    "C20719",
                    "C3367",
                    "C25870",
                    "C20103"
                ],
                "parents": [
                    "C16152",
                    "C17756",
                    "C177692"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C20719",
                    "C35681",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C16152",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "exclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Exclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C101267",
                "name": "Hormone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C20420",
                    "C28656",
                    "C16612",
                    "C94299",
                    "C38349",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C177692",
                    "C21295",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C177692",
                    "C188928",
                    "C28656",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2022-07-25",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C170728",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic HER2 Positive Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C180924",
                "name": "Metastatic HER2-Positive Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165698",
                    "C53556"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Hormone Receptor Positive Breast Carcinoma",
                    "Metastatic Hormone Receptor Positive Breast Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C185880",
                "name": "Metastatic Hormone Receptor-Positive Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C157056",
                    "C165698"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Adenocarcinoma of Breast",
                    "Mammary adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Breast",
                    "Tumor of Breast",
                    "Breast Tumor",
                    "Neoplasm of the Breast",
                    "Neoplasm of Breast"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26709",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Neoplasm of the Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C2910"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of the Breast",
                    "Cancer of Breast",
                    "Carcinoma of Breast",
                    "Breast cancer, NOS",
                    "Mammary Carcinoma",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9335",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "HER2 Overexpressing Subtype of Breast Carcinoma",
                    "HER2 Positive Breast Carcinoma",
                    "ERBB2 Overexpressing Subtype of Breast Carcinoma",
                    "HER2 Positive Breast Cancer",
                    "HER2 Overexpressing Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C53556",
                "name": "HER2-Positive Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C53553"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Hormone Receptor Positive Breast Adenocarcinoma",
                    "Hormone Receptor-Positive Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C157056",
                "name": "Hormone Receptor Positive Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C53553",
                "name": "Breast Carcinoma by Gene Expression Profile",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165698",
                "name": "Metastatic Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153238",
                    "C4124",
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "17-0919",
        "active_sites_count": 0,
        "lead_org_cancer_center": "Tisch Cancer Institute",
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Anti-tumor Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK6 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C192742",
                        "name": "Cyclin-Dependent Kinase 6 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2185"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK4 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C192741",
                        "name": "Cyclin-Dependent Kinase 4 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2185"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Protein Antagonist",
                            "Anti-cancer Protein Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologics",
                            "Biologics",
                            "Biological Products",
                            "Biopharmaceuticals",
                            "Biologicals",
                            "Immunologic, Immunochemical"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "ERBB2-Targeting Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163760",
                        "name": "HER2-targeting Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy Agent",
                            "Hormone Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Ontruzant",
                            "Herceptin",
                            "Kanjinti",
                            "Trazimera",
                            "Ogivri",
                            "Herzuma"
                        ],
                        "nci_thesaurus_concept_id": "C1647",
                        "name": "Trastuzumab",
                        "description": "A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C155711"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Procedure",
                            "Intervention",
                            "Intervention Strategies"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Anticancer Antibody",
                            "Antineoplastic Ab"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Perjeta"
                        ],
                        "nci_thesaurus_concept_id": "C38692",
                        "name": "Pertuzumab",
                        "description": "A humanized recombinant monoclonal antibody directed against the extracellular dimerization domain of the HER-2 tyrosine kinase receptor. Binding of the antibody to the dimerization domain of the HER-2 tyrosine kinase receptor protein directly inhibits the ability of the HER-2 tyrosine kinase receptor protein (the most common pairing partner) to dimerize with other HER tyrosine kinase receptor proteins; inhibiting receptor protein dimerization prevents the activation of HER signaling pathways, resulting in tumor cell apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C155711"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Anti-tumor Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Laboratory Test",
                            "Tests",
                            "Lab Tests",
                            "Test",
                            "Lab Test"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-ErbB2 Monoclonal Antibody",
                            "Anti-HER-2 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C155711",
                        "name": "Anti-HER2 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129822",
                            "C163760",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Non-Steroidal Androstenedione Aromatase Inhibitor",
                            "Non-Steroidal Estrogen Synthetase Inhibitor",
                            "Non-Steroidal Estrogen Synthase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2018",
                        "name": "Non-Steroidal Aromatase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1740"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Estrogen Synthase Inhibitor",
                            "Estrogen Synthetase Inhibitor",
                            "Androstenedione Aromatase Inhibitor",
                            "Aromatase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C1740",
                        "name": "Aromatase Inhibition Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C481",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiestrogenic",
                            "Antiestrogen Therapy Agent",
                            "Antiestrogens",
                            "Antiestrogen",
                            "Estrogen Antagonist",
                            "Estrogen Inhibitor",
                            "Anti-Estrogens"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Endocrinal Agent",
                            "Antineoplastic Hormonal Agent",
                            "Antineoplastic Hormonal Therapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2185",
                        "name": "Cyclin-Dependent Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Ibrance"
                        ],
                        "nci_thesaurus_concept_id": "C49176",
                        "name": "Palbociclib",
                        "description": "An orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine/threonine kinases that are upregulated in many tumor cell types and play a key role in the regulation of cell cycle progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C192742",
                            "C192741",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Arimidex"
                        ],
                        "nci_thesaurus_concept_id": "C1607",
                        "name": "Anastrozole",
                        "description": "A nonsteroidal inhibitor of estrogen synthesis that resembles paclitaxel in chemical structure.  As a third-generation aromatase inhibitor, anastrozole selectively binds to and reversibly inhibits aromatase, a cytochrome P-450 enzyme complex found in many tissues including those of the premenopausal ovary, liver, and breast; aromatase catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.  In estrogen-dependent breast cancers, anastrozole may inhibit tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2018"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormone Antagonist",
                            "Antihormone Agents"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunopotentiators",
                            "Immune Mediators",
                            "Immunomodulating Agent",
                            "BRM",
                            "Biomodulators",
                            "Biological Response Modifier",
                            "Immunomodulators",
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Immunotherapeutic Agent",
                            "Immune Regulators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C74957",
                            "C63333"
                        ]
                    }
                ],
                "name": "Treatment (anastrozole, palbociclib, trastuzumab, pertuzumab)",
                "description": "Participants receive anastrozole PO QD on days 1-28, and palbociclib PO QD on days 1-21. Participants also receive trastuzumab IV over 30-90 minutes and pertuzumab IV over 30-60 minutes once every 21 days. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-00678",
        "why_study_stopped": null,
        "brief_summary": "This phase I/II trial studies the side effects and best dose of anastrozole, palbociclib, trastuzumab and pertuzumab and how well they work in treating participants with hormone receptor-(HR) positive, HER2-positive breast cancer that has spread to other locations in the body. Anastrozole and palbociclib are enzyme inhibitors that may stop the growth of tumor cells by blocking some of the enzymes needed cell growth. Trastuzumab is a form of targeted therapy because it attaches itself to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors. When trastuzumab attaches to HER2 receptors, the signals that tell the cells to grow are blocked and the cancer cell may be marked for destruction by the body's immune system. Monoclonal antibodies, such as pertuzumab may interfere with the ability of tumor cells to grow and spread. Giving anastrozole, palbociclib, trastuzumab and pertuzumab may work better in treating participants with HR+, HER2+ metastatic breast cancer.",
        "brief_title": "Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in Treating Participants with HR-Positive, HER2-Positive Metastatic Breast Cancer",
        "status_history": [
            {
                "status_date": "2022-07-25T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2017-10-03T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 43,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2017-10-03",
        "record_verification_date": "2023-01-12",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": "Amy Diane Tiersten",
        "study_source": "Institutional",
        "completion_date": "2023-07-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]